Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

USANA HEALTH SCIENCES, INC.

(USNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

USANA Health Sciences : Q2 Results Rise from Year Ago, Reaffirms Full-Year Guidance

07/27/2021 | 04:49pm EDT


ę MT Newswires 2021
All news about USANA HEALTH SCIENCES, INC.
09/27USANA : Board Member Peggie Pelosi Named to the NACD Directorship 100
PR
09/22USANA HEALTH SCIENCES : Yin Yang You, a global collaboration 5,000 years in the making
PR
09/16USANA HEALTH SCIENCES : Scales Back 2021 Revenue, Earnings Outlook -- Shares Drop 5% After..
MT
09/16GUIDANCE : (USNA) USANA HEALTH SCIENCES Sees Q3 Revenue Range $265M - $270M
MT
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates Fiscal Year..
PU
09/16USANA HEALTH SCIENCES INC : Regulation FD Disclosure (form 8-K)
AQ
09/16USANA HEALTH SCIENCES : Provides Preliminary Third Quarter Results and Updates Fiscal Year..
BU
09/16USANA Health Sciences, Inc. Revises Earnings Guidance for the Full Year 2021
CI
09/16USANA Health Sciences, Inc. Provides Earnings Guidance for the Third Quarter of 2021
CI
09/16USANA Health Sciences, Inc. announces an Increase in Equity Buyback.
CI
More news
Analyst Recommendations on USANA HEALTH SCIENCES, INC.
More recommendations
Financials (USD)
Sales 2021 1 193 M - -
Net income 2021 121 M - -
Net Debt 2021 - - -
P/E ratio 2021 15,3x
Yield 2021 -
Capitalization 1 826 M 1 826 M -
Capi. / Sales 2021 1,53x
Capi. / Sales 2022 1,51x
Nbr of Employees 1 943
Free-Float 60,0%
Chart USANA HEALTH SCIENCES, INC.
Duration : Period :
USANA Health Sciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends USANA HEALTH SCIENCES, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 91,26 $
Average target price 90,00 $
Spread / Average Target -1,38%
EPS Revisions
Managers and Directors
Kevin G. Guest Chairman & Chief Executive Officer
Jim Brown President
G. Douglas Hekking Chief Financial Officer
Myron W. Wentz Chairman-Emeritus
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
USANA HEALTH SCIENCES, INC.18.64%1 831
BY-HEALTH CO., LTD.17.18%7 468
BALCHEM CORPORATION27.70%4 763
HERBALIFE NUTRITION LTD.-8.32%4 651
THE SIMPLY GOOD FOODS COMPANY12.02%3 365
MEDIFAST, INC.3.74%2 457